ReferenceID 4430
Acacetin ameliorates cardiac hypertrophy by activating Sirt1/AMPK/PGC-1α pathway
Eur J Pharmacol
Cardiac hypertrophy is a major risk factor for developing heart failure. This study investigates the effects of the natural flavone acacetin on myocardial hypertrophy in cellular level and whole animals. In cardiomyocyte
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 4430
- Evidence Id
- 21020
- Core Evidence Id
- 21020
- Source Reference Id
- 2139
- Herb2 Reference Id
- HBREF002936
- Subject Paper Key
- HBIN014294_35219729
- Pubmed Id
- 35219729
- Doi
- 10.1016/j.ejphar.2022.174858
- Paper Title
- Acacetin ameliorates cardiac hypertrophy by activating Sirt1/AMPK/PGC-1α pathway
- Paper Abstract
- Cardiac hypertrophy is a major risk factor for developing heart failure. This study investigates the effects of the natural flavone acacetin on myocardial hypertrophy in cellular level and whole animals. In cardiomyocytes from neonatal rat with hypertrophy induced by angiotensin II (Ang II), acacetin at 0.3, 1, and 3 μM reduced the increased myocyte surface area, brain natriuretic peptide (BNP), and ROS production by upregulating anti-oxidative molecules (i.e. Nrf2, SOD1, SOD2, HO-1), anti-apoptotic protein Bcl-2, and downregulating the pro-apoptotic protein Bax and the inflammatory cytokine IL-6 in a concentration-dependent manner. In addition, acacetin rescued Ang II-induced impairment of PGC-1α, PPARα and pAMPK. These beneficial effects of acacetin were mediated by activation of Sirt1, which was confirmed in cardiac hypertrophy induced by abdominal aorta constriction (AAC) in SD rats. Acacetin prodrug (10 mg/kg, s.c., b.i.d.) treatment reduced the elevated artery blood pressure, improved the increased heart size and thickness of left ventricular wall and the ventricular fibrosis associated with inhibiting myocardial fibrosis and BNP, and reversed the impaired protective signal molecules including PGC-1α, Nrf2, PPARα, pAMPK and Sirt1 of left ventricular tissue. Our results demonstrate the novel pharmacological effect that acacetin ameliorates cardiac hypertrophy via Sirt1-mediated activation of AMPK/PGC-1α signal molecules followed by reducing oxidation, inflammation and apoptosis.
- Journal
- Eur J Pharmacol
- Publish Year
- 2022
- Experiment Subject
- rat
- Experiment Type
- Animal & Cell Experiment
- Phenotype Related
- Myocardial Fibrosis; Myocardial Hypertrophy; Cardiac Hypertrophy; Abdominal Aorta Constriction; Heart Failure; Ventricular Fibrosis; Hypertrophy
- Paper Title Cn
- Paper Title En
- Acacetin ameliorates cardiac hypertrophy by activating Sirt1/AMPK/PGC-1α pathway
- Bilingual Status
- semi_complete